Gilead Moves Into Microbiome In Deal With Second Genome

 
• By Joseph Haas
  
Biofilm - Microbiome - Abstract 3D Illustration
Second Genome will apply its microbiome screening technology to existing Gilead pipeline assets
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business